1.Astrocyte elevated gene 1 in malignant tumor
Journal of International Oncology 2012;39(5):341-344
Recent studies suggest that astrocyte elevated gene 1 ( AEG-1 ) is almost highly expressed in all types of malignant solid tumors and correlates with poor prognosis,which becomes a prognostic marker for many kinds of tumors.As a strongly basic protein,AEG-1 possesses a transmembrane domain and multiplenuclear localization signals.It is present in the cell membrane,cytoplasm and nucleus.As an oncogene,AEG-1 palys an important role in a virety of malignant biological behaviors of cancer,which range from cell proliferation,apoptosis,migration,adhesion,invasion to tumor angiogenesis and chemotherapy resistance.Its critical role in tumor genesis and progression has made it a potential therapeutic target.
2.Skin toxicities of epidermal growth factor receptor inhibitors
Journal of International Oncology 2012;39(10):784-787
Skin toxicities are the most common adverse effects of epidermal growth factor receptor inhibitors(EGFRI).It can result in significant physical and psyehological discomfort,and even leads to interruption or dose modification,and consequently affect the curative effect. Nowadays this adverse effect has attracted lot of attention.It is proposed that clinical management and treatment measures for skin toxicities should be further studied to improve the patients life quality,and guarantee the continuity and best curative effect of the treatment.But more researches on the pathogenesis and its prognostic significance are still expected.
3.Clinical Application of the Alginate Microglobe Particles in Partial Splenic Embolization for Hypersplenism in Cirrhosis
Journal of Practical Radiology 1991;0(03):-
Objective To elevate the efficacy and complications of partial splenic embolization(PSE) using the alginate microglobe(AMG) as embolic material for hypersplenism in cirrhosis.Methods 42 patients with hypersplenism and cirrhosis were treated by PSE,AMG of 250~450 ?m were injected into the arteries of inferior splenic pole,the embolization degree was ranging from 40% to 70%.Results 42 times of embolization were performed in 42 patients,after operation, 35 patients had fever and lasted for 3~15 d,38 patients had abdominal pain,of them, 27 patients needed treatment with analgesic.Treatable a little hydrothorax appeared in 6 ,and no serious complication occurred.WBC and PLT counts were increased 24 hour later(P
4.Research development of triple-negative breast cancer chemotherapy
Journal of International Oncology 2012;39(1):27-31
Triple-negative breast cancer ( TNBC ) is a subtype of breast cancer,and it is characterized by an aggressive clinical course with a poor prognosis.Treatment for TNBC has attracted much attention in recent years,however,there is no standard treatment for TNBC in clinical setting.The pCR rates of neoadjuvant chemotherapy in TNBC ranges from 12% to 48% in the current published data,and it is higher than that in other types of breast cancer,however,the fluctuating range of the TNBC ’s pCR is large in literature.Although the administration of adjuvant chemotherapy for early TNBC is controversial,the regimen without anthracyclines is reported to be suitable for early TNBC patients.Standard cytotoxic agents including taxanes and anthracyclines are still the main choices for TNBC salvage treatment,and the combination with gemcitabine or capecitabine may improve the overall survival.Poly (ADP-ribose) polymerase (PARP) is a new molecular target for TNBC in ongoing studies.Further research on the target-inhibitors such as BSI-201and Olaparib will provide more effective choices to clinical treatment.
5.Application of cytokine-induced killer ceils in tumor therapy
Journal of International Oncology 2011;38(2):102-105
Cytokine-induced killer(CIK)cells are characterized by rapid proliferation, high and broad anti-tumor activities and mild toxicities. Some clinical trials demonstrate that the infusion of a large amount of CIK cells enhances the auto-immune of function in patient, which might help to clean up the remaining tumor cells and minor metastatic tumors and delay the recurrence of tumor with improved curative effects.
6.Adverse reactions of the new generation of tumor immunotherapy and its management strategy
Journal of International Oncology 2017;44(6):460-463
In recent years,tumor immunotherapy has attracted more attention because of its remarkable curative effect in patients with advanced cancer,but often accompanied by immune related adverse events.Understanding the immune related adverse reaction rate,possible mechanism and adverse reaction evaluation criteria and treatment principle of the immune checkpoint inhibitors such as Ipilimumab,Nivolumab and Pembrolizumab,has important significance for the treatment of malignant tumor.
7.Obesity and breast cancer
Heng CAO ; Xiaodong XIE ; Zhaozhe LIU
Journal of International Oncology 2012;39(4):268-271
Obesity has been identified as one of the risk factors for malignant neoplasms,such as breast cancer.Epidemiological data shows that obesity is closely related to the development and progression of breast cancer.The pathogenesis may involve in estrogen,insulin,leptin,adiponectin and inflammation factors.Therefore,maintain normal body weight may contribute to the prevention of breast cancer.
8.Cytokine-induced killer cells in cancer treatment
Xuefeng HANG ; Zhenyu DING ; Xiaodong XIE
Journal of International Oncology 2012;39(5):344-347
Cytokine-induced killer cells (CIK) is the fourth largest cancer treatment after surgery,chemotherapy and radiotherapy,and it is the development direction of cancer treatment.It is a new type of immune cell,and it is named after natural killer cell samples T lymphocytes as it express CD3 and CD56.Currently,CIK treatment has a broader range of clinical applications,and it has achieved the better clinical efficacy in the blood system cancer and solid tumors,The CIK adoptive immunotherapy is considered to be a new hope for the anticancer treatment.
9.The study of the effects of nuclear factor-KB inhibitor on infant rabbits with mechanical ventilation-induced lung injury
Lijuan XIE ; Jianxing ZHU ; Xiaodong ZHU
Journal of Clinical Pediatrics 2009;(9):801-806
Objective To investigate the protective effects and mechanisms of NF-KB inhibitor pyrrolidine dithiocarbamate (PDTC) on infant rabbits with lung injury caused by mechanical ventilation. Methods Twenty healthy infant rabbits were randomly divided into four groups. (1) Mechanical ventilation (MV, with VT = 24 ml/kg);(2) Mechanical ventilation plus PDTC pre-treatment (MVP, VT = 24 ml/kg with PDTC 100 mg/kg injection via ear vein half an hour prior to MV) ; (3) Mechanical ventilation combined with endotoxin (EMV, 0.1 ml/kg of endotoxin dripping into trachea then on MV, VT = 24 ml/kg) ; (4) EMV plus PDTC pretreatment (EMVP, PDTC 100 mg/kg injection via ear vein followed by 0.1 mg/kg of endotoxin dripping into trachea in half an hour then on MV with VT = 24 ml/kg for 4 h continuously. MPO and the activation of NF-κB in lung tissues and the genetic expression and protein quantity of TNF-α and IL-8 in homogenate were measured. The pathological changes in lung tissues were examined. Results Pre-treatment with PDTC had significant minor pathological changes caused by MV and MV plus endotoxin, which were indicated by the fact that MPO, activation of NF-KB and the genetic expression and protein quantity of TNF-α and IL-8 were significantly suppressed. Conclusions PDTC could decrease the expression, synthesis and release of pro-inflammatory cytokines. This may be through suppressing the activation of NF-κB resulting in less infiltration with inflammatory cells and protective effects on lung injury caused by MV and MV plus endotoxin.
10.Caring sarcopenia for cancer patients: review
Lu WANG ; Yongchun CHEN ; Xiaodong XIE
Chinese Journal of Clinical Nutrition 2013;21(1):23-29
Sarcopenia is one of common clinical symptom in patients with cancer,which can be regarded as a poor prognosis independent risk factors of disease and death.The main measurements of sarcopenia are magnetic resonance imaging,computerized tomography and positron emission tomography.Sarcopenia is frequently associated with cachexia,and have an influence on the anti-tumor therapeutic influence with each other.In recent years,a mass of clinical research on the application of exercise,nutrition support and drugs,and other comprehensive intervention in patients with sarcopenia emerging constantly,and much achieved good results.The clinical value of sarcopenia in cancer therapy can not be ignored,which should be given more attention.Its mechanism is complex,and intervention means become more various,but more evidence of efficacy and safety is still needed.